Complex Medical Patients Wayne Katon, MD.  Definition: Illnesses with high prevalence, high comorbidity and bidirectional adverse interactions Examples:

Slides:



Advertisements
Similar presentations
Patient Safety and Quality of Care: Role of the Compliance Professional Harvey V. Fineberg, M.D., Ph.D. Sixth Annual National Congress on Health Care Compliance.
Advertisements

June 25, 2006 Propensity Score Adjustment in Survival Models Carolyn Rutter Group Health Cooperative AcademyHealth, Seattle WA.
Introduction Medication non adherence ( noncompliance) remains a major problem. You have to assess and treat adherence related problems that can adversely.
1 Type 1 Diabetes Mellitus Treatment. 2 Goals of T1DM Management Utilize intensive therapy aimed at near-normal BG and A1C levels Prevent diabetic ketoacidosis.
Managing T2DM during Ramadan Dr. Asrar Said Hashem Specialist in Internal Medicine (Al-Amiri Hospital) Fellow of KIMS Endocrine, Diabetes and Metabolism.
“ Handle with Care” A GP guide to cancer care for elderly patients.
Disease State Management The Pharmacist’s Role
Foos et al, EASD, Lisbon, 13 September 2011 Comparison of ACCORD trial outcomes with outcomes estimated from modelled and meta- analysis studies Volker.
National Diabetes Statistics Report Fun Facts on Diabetes 29.1 million people or 9.3% of the US population have diabetes. Diagnose : 21.0 million people.
PEBB Disease Burden Report PEBB Board of Directors August 21, 2007 Bdattach.10.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence July-August 2007.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence January–February 2009.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence November-December 2007.
Facts and Fiction about Type 2 Diabetes Michael L. Parchman, MD Department of Family & Community Medicine September 2004.
Diabetes Disabilities Dr Abeer Al-Saweer. Lecture Layout Definition of Disabilities Spectrum of Disabilities Diabetes and Disabilities Factors related.
Disclosure: Wayne Katon, MD LillyWyethForestPfizer IIII II Company Employment Management Independent Contractor Consulting Speaking & Teaching Board, Panel.
Behavioral Health in Health Care Reform: Why and How? Mike Hogan, Ph.D. Commissioner, NYS Office of MH Chair, Pres. NFC on Mental Health (2002-3)
Source: Site Name and Year IHS Diabetes Audit Diabetes Health Status Report ______Site Name_________ Health Outcomes and Care Given to Patients with Diabetes.
METABOLIC SYNDROME Dr Gerhard Coetzer. Complaint Thirsty all the time Urinating more than usual Blurred vision Tiredness.
Rapid E clinical guidance in the management of Type 2 diabetes New Zealand Guidelines Group.
Individualizing Targets and Tactics for High- Risk Patients With Type 2 Diabetes Practical lessons from ACCORD and other cardiovascular trials Featured.
Incentives for Medical Practice Transformation: The Bridges to Excellence Initiatives A. O’tayo Lalude, MD Louisville, Kentucky at The Third Annual HIT.
Healthcare Reform The “Affordable Care Act” How Will It Affect Substance Abuse Care?
PERIODIC MEDICAL EXAMINATION BY DR. ANGELA ESOIMEME MBBS, MPH, FWACGP.
Diabetes Mellitus 101 for Cardiologists (and Alike): 2015 Stan Schwartz MD,FACP Affiliate, Main Line Health System Emeritus, Clinical Associate Professor.
Glucose Control and Monitoring
Lancet 373: , 2009 Baseline Characteristics of Participants and Study Design of Clinical Trials to Compare Intensive glucose- lowering versus.
Alcohol Consumption and Diabetes Preventive Practices: Preliminary Findings from the U.S.-Mexico Border Patrice A.C. Vaeth, Dr.P.H. Raul Caetano, M.D.,
Individualization Strategies for Older Patients with Diabetes Elbert S. Huang, MD MPH FACP University of Chicago.
Psychology at Stormont 24 th September Health Psychologists … Work with people who need to manage physical health and illness issues, including:
+ Effects of Quality Improvement Strategies on Diabetes Care Presented by: Cali Trepp, Caitlin Dowhie, and Rosa Sanchez.
Mary Gardner, RN, MA, CCM, CDE Program Manager, High Risk Diabetes and COPD XLHealth Member Management Using The Med-eXpert System and Med-eMonitor Patient.
 In a world full of processed sugars and fast food dollar menus, it is no wonder “more than 1 in 10 health care dollars in the U.S. are spent directly.
Using QOF and Service Specifications to meet HI Needs Rachel Foskett-Tharby.
Therapy of Type 2 Diabetes Mellitus: UPDATE Glycemic Goals in the Care of Patients with Type 2 Diabetes ADA and AACE Guidelines: Room For Improvement.
Diabetes Health intelligence Jon Walker Advanced public health analyst Surrey County Council
Achieving Glycemic Control in the Hospital Setting (Part 2 of 4)
Diabetes Health intelligence Jon Walker Advanced public health analyst Surrey County Council
Diabetes Mellitus 101 for Cardiologists (and Alike): 2015
Disability, Frailty and Co-Morbidity L. Fried et al. Gero 302 Jan 2012.
Part 3. Diabetes Report Card: HbA 1c Levels in the United States Hoerger TJ, et al. Diabetes Care. 2008;31: Patients (%) HbA 1c (%)
Helping Medical Students Counsel Patients With Uncontrolled Type II Diabetes: An Innovative Approach Alice Fairman Daniels, MD,MS Assistant Professor Cook.
Improving Adherence in Type 2 Diabetes Mellitus ALLISON PETZNICK DO NOMS FAMILY MEDICINE SANDUSKY, OH.
Medical Management of Diabetes During Ramadan Jennifer Hamilton, MD August, 2007 CE Rajab, 1428 AH.
Pharmacy Health Information Technology Collaborative Presenter: Shelly Spiro RPh, FASCP Pharmacy HIT Collaborative, Executive Director.
Circulation. 2014;129: Association Between Plasma Triglycerides and High-Density Lipoprotein Cholesterol and Microvascular Kidney Disease and Retinopathy.
Assessing health literacy and polypharmacy in a homeless substance abuse treatment facility Nathan D. Culver, Pharm.D., BCPS; Camille Agosto, Student Pharmacist;
Alcohol, Other Drugs, and Health: Current Evidence July–August 2017
Redefining Quality Care in T2DM Patients with CV Disease
The Role of Depression in Effective Chronic Disease Management
Nathan D. Culver, Pharm.D., BCPS; Hera Saleem, Student Pharmacist;
Diabetes Health Status Report
Heart Health & Diabetes
Serious Mental Illness and Diabetes Care Among California Adults
Overview of Disparities
Systolic Blood Pressure Intervention Trial (SPRINT)
Principles of Disease Management: Physician View (paper-based)
برنامه راهبردی پیشگیری و کنترل بیماری های قلبی عروقی
Hemoglobin A1c Targets for Glycemic Controls
Health and Disease Management
Developing and Using a Referral Network
Type 2 diabetes.
Although adverse childhood events may account for only a small proportion of the current obesity epidemic in the U.S. (Alvarez et al., 2007), risk of obesity.
Senator Ron D. Stollings, MD, FACP
Pharmacotherapy for Diabetic Coronary Disease:
Pharmaceutical care planning 2 Ola Ali Nassr
Non-communicable disease, health, disease
Diabetes Self-Management Education and Support: Component of Standard Diabetes Care 1, 2 “… Ongoing patient self-management education and support are.
Grace K. Mahoney, MS, Henry J. Henk, PhD, Rozalina G. McCoy, MD, MS 
Adjusted HRs for death from any cause and death from specific causes among patients with type 1 diabetes. Adjusted HRs for death from any cause and death.
Presentation transcript:

Complex Medical Patients Wayne Katon, MD

 Definition: Illnesses with high prevalence, high comorbidity and bidirectional adverse interactions Examples: Diabetes, CAD, depression Depression, chronic pain, substance abuse Challenge: Development of Health Services Models for “Natural” Clusters of Illness

 Many measures of processes of care lack strong links to outcomes  Actionable processes of care are not measured  Measures do not target those at highest risk  Measures do not allow for patient exceptions  Intermediate outcome measures are not severity adjusted Pitfalls of Processes of Care Measures Kerr E et al. 2001

“Tightly Linked” Quality of Care Measures  Evidence links these process measures to improved outcomes  Adding a beta-blocker to HCTZ in patients with poorly controlled blood pressure Kerr E et al. 2001

161,697 Patients with Diabetes were Examined to Estimate Rates and Reasons for Poor Disease Control (HbA 1c, SBP, LDLs)  20% to 23% poor adherence  Among those with adequate adherence, 30% to 47% had no evidence of treatment intensification  Poor adherence and lack of treatment intensification were found in 53% to 68% of patients with poor disease control Schmittdiel J et al. 2008

Comorbid Depression & Diabetes Adversely affects self-care: adherence to diet, exercise, cessation of smoking, taking medications as prescribed Does not affect quality of care measures under more direct physician control):  Number of HbA 1c, LDL tests, annual retinal and foot exams  Intensification of medication in patients with poor disease control Comorbid Depression & Diabetes

ACCORD, ADVANCE and VADT Trials  Limited evidence that intensive glucose control decreased macrovascular events  Subset analysis suggested that patients with shorter duration of diabetes without established atherosclerosis might benefit from intensive glucose control  Risks of intensive glucose control might outweigh benefits in those with a long history of diabetes, known history of hypoglycemia, advanced atherosclerosis and advanced age/fragility Skyler et al. 2009